Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia

Journal of Neural Transmission, Supplement

Volumn , Issue 53, 1998, Pages 237-250

  Mielke, R ^a   Heiss, W D ^a  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; GLUCOSE METABOLISM; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AGED; BRAIN; BRAIN LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; PHYSIOLOGY; REVIEW; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031596273     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6467-9_21     Document Type: Article

References (65)

1. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd rev. edn. American Psychiatric Association, Washington DC
2. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluordeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. Arch Neurol 40: 711-714
3. Breitner JCS, Silverman JM, Mohs RC, Davis KL (1988) Familial aggregation in Alzheimer's disease: comparison od risk among relatives of early- and late-onset cases, and among male and female relatives in successive generations. Neurology 38: 207-212
4. Chase TN, Foster NL, Mansi L (1983) Alzheimer's disease and the parietal lobe. Lancet ii: 225
5. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R (1992) Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centers. Neurology 42: 473-480
6. DeCarli C, Kaye JA, Horwitz B, Rapoport SI (1990) Critical analysis of the use of computer assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 40: 872-883
7. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Larson S, Rapoport SI (1986) Positron emmission tomography in Alzheimer's disease. Neurology 36: 879-887
8. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental State: a practical method for grading the cognitive status of patients for the clinician. J Psychiatr Res 12: 189-198
9. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer's disease: focal cortical changes shown by positron emission tomography. Neurology (Cleveland) 33: 961-965
10. Frackowiak RSJ, Pozzilli C, Legg NJ, du Boulay GH, Marshall J, Lenzi GL, Jones T (1981) Regional cerebral oxygen supply and utilization in dementia. Brain 104: 753-778
11. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer's type: positron emission tomography with (18F)fluordeoxyglucose. J Comput Assist Tomogr 7: 5590-598
12. Gemmel HG, Sharp PF, Besson JAO, Crawford JR, Ebmeier KP, Davidson J, Smith FW (1987) Differential diagnosis in dementia using cerebral blood flow agent TC-99m HM-PAO: a SPECT study. J Comput Assist Tomogr 11: 398-402
13. Gemmell HG, Sharp PF, Besson JAO, Ebmeier KP, Smith FW (1988) A comparison of TC-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia. Eur J Nucl Med 14: 463-466
14. 2 PET. J Nucl Med 31: 1595-1600
15. Gibbs JM, Frackowiak RSJ, Legg NJ (1986) Regional cerebral blood flow and oxygen metabolism in dementia due to vascular disease. Gerontology 32 [Suppl 1]: 84-86
16. Grady CL, Haxby JV, Horwitz B, Berg G, Rapoport SI (1987) Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type. Neuropsychologia 25: 807-816
17. Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro M, Friedland RP, Rapoport SI (1988) Longitudinal study of the early neuropsychological and cerebral changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 10: 576-596
18. Hachinski VC, Iliff LD, Zilhka E, DuBoulay GH, McAllister VL, Marshall J, Russell RWR, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32: 632-637
19. Haxby JV, Grady CL, Duara R, Schlageter N, Berg G, Rapoport SI (1986) Neocortical abnormalities precede nonmemory cognitive defects in early Alzheimer's type dementia. Arch Neurol 43: 882-885
20. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI (1990) Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 47: 753-760
21. Heiss WD, Ilsen HW, Wagner R, Pawlik G, Wienhard K, Eriksson L (1983) Remote functional depression of glucose metabolism in stroke and its alteration by activating drugs. In: Heiss WD, Phelps ME (eds) Positron emission tomography of the brain. Springer, Berlin Heidelberg New York Tokyo, pp 162-168
22. Heiss WD, Hebold I, Klinkhammer P, Ziffling P, Szelies B, Pawlik G, Herholz K (1988) Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. J Cereb Blood Flow Metab 8: 613-617
23. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K (1994) Long-term effects of Phosphatidylserine, Pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia 5: 88-98
24. Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD (1990) Criteria for the diagnosis of Alzheimer's disease with positron emission tomography. Dementia 1: 156-164
25. Heston LL, Mastri AR, Anderson VE, White J (1981) Dementia of the Alzheimer type. Clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 38: 1085-1090
26. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B (1988) Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 38: 909-912
27. Kamo H, McGeer P, Harrop R, McGeer E, Calne D, Martin W, Pate B (1987) Positron emission tomography and histopathology in Pick's disease. Neurology 37: 439
28. Kase CS (1991) Epidemiology of multi-infarct dementia. Alz Dis Assoc Disord 5: 71-76
29. Kennedy AM, Newman S, Clegg F, Tyrrell P, Warrington EK, Roques P, Hardy J, Rossor MN, Frackowiak RSJ (1992) Imaging in dementia: longitudinal studies using positron emission tomography. Neurobiol Aging 13: S13
30. Kessler J, Herholz K, Heiss WD (1991) Impaired metabolic activation in Alzheimer's disease: a PET study during continous visual recognition. Neuropsychologia 29: 229-243
31. Klinkhammer P, Szelies B, Heiss WD (1990) Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer's disease. Dementia 1: 197-201
32. Kraepelin E (1910) Psychiatrie, ein Lehrbuch für Studierende und Ärzte, 8th edn, vol II/ 1. Barth, Leipzig
33. Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J (1980) Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 8: 47-60
34. Kuhl D, Phelps M, Markham C (1982) Cerebral metabolism and atrophy in Huntington's disease determined by 18-FDG and computed tomographic scan. Ann Neurol 12: 425-434
35. Kuhl DE, Metter EJ, Riege WH, Hawkings RA, Mazziotta JC, Phelps DE, Kling AS (1983) Local cerebral glucose utilization in elderly patients with depression, multiple infarct dementia and Alzheimer's disease. J Cereb Blood Flow Metab 3: S494-S495
36. Kuhl D, Metter E, Benson F, Ashford JW, Riege WH, Fujikawa DG, Markham CH, Mazziotta JC, Maltese A, Dorsey DA (1985) Similarities of cerebral glucose metabolism in Alzheimer's and Parkinson's dementia. J Cereb Blood Flow Metab 5: 169-170
37. Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113: 1405-1423
38. Mann DMA, Yates PO, Marcyniuk B (1984) Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age from an age related continuum of pathological changes. Neuropathol Appl Neurobiol 10: 185-207
39. McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB (1986) Positron emission tomography in patients with clinical diagnosed Alzheimer's disease. Can Med Assoc J 134: 597-607
40. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 19: 939-944
41. Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, Del Sole A, Franceschi M, Gilardi MC, Fazio F (1994) High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET. J Nucl Med 35: 210-216
42. Mielke M, Ghaemi J, Kessler B, Kittner B, Szelies B, Herholz K, Heiss WD (1998) Propentofylline enhances cerebral metabolic response to auditory memory stimulation in Alzheimer's disease. J Neurol Sci (in press)
43. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 13: 93-98
44. Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD (1994) HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Eur J Nucl Med 21: 1052-1060
45. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1994) Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36-41
46. Mielke R, Jacobs A, Kessler J, Pietrzyk U, Herholz K, Heiss WD (1995) Diagnostic accuracy of FDG PET and HMPAO SPECT for the differentiation between Alzheimer's disease and vascular dementia depends on severity of disease. J Neurol 241: 35
47. Mielke R, Schröder R, Fink G, Kessler J, Herholz K, Heiss WD (1996) Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol 91: 174-179
48. Mielke R, Ghaemi M, Kittner B, Kessler J, Szelies B, Herholz K, Heiss WD (1996) Propentofylline improves regional cerebral glucose metabolism and neuropsy-chological performance in vascular dementia. J Neurol Sci 141: 59-64
49. Morris JC, McKeel Jr DW, Fulling K, Torack RM, Berg L (1988) Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 24: 17-22
50. Nordberg A, Lilja A, Lundqvist H, Hartvig P, Amberla K, Viitanen M, Warpman U, Johansson M, Hellstrom-Lindahl E, Bjurling P (1992) Tacrine restores cholinergic nicotinic receptors and glucose-metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol Aging 13: 747-758
51. Podreka I, Suess E, Goldenberg G, Steiner M, Brücke T, Müller CH, Lang W, Neirinckx RD, Deecke L (1987) Initial experience with Technetium-99m HM-PAO brain SPECT. J Nucl Med 28: 1657-1666
52. Rapoport SI, Hatanpää K, Brady DR, Chandrasekaran K (1996) Brain energy metabolism, cognitive function and down-regulated oxidative phosphorylation in Alzheimer's disease. Neurodegeneration 5: 473-476
53. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozzo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Neurology 43: 250-260
54. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset type of Alzheimer's disease. Br Med J 288: 961-964
55. Roth MN (1986) The association of clinical and neurobiological findings and its bearing on the classification and aetiology of Alzheimer's disease. Br Med Bull 42: 42-50
56. Sacquegna T, DeCarolis P, Daidone R, Dondi M (1988) Single-photon emission tomography with technetium Tc 99m hexamethylpropylene amine oxime in Binswanger's disease. Arch Neurol 45: 603-604
57. Small GW. Kuhl DE, Riege WH, Fujikawa DG, Ashford JW, Metter EJ, Mazziotta JC (1989) Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. Arch Gen Psychiat 46: 527-532
58. StGeorge-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Broeckhoven C, Goate A, McLachlan DRC, Orr H, Bruni AC, Sorbi S, Rainero I, Foncin JF, Pollen D, Cantu JM, Tupler R, Voskresenskaya N, Mayeux R, Growdon J, Fried VA, Myers RH, Nee L, Backhovens H, Martin JJ, Rossor M, Owen MJ, Mullan M, Percy ME, Karlinsky H, Rich S, Heston L, Montesi M, Mortilla M, Nacmias N, Gusella JF, Hardy JA (1990) Genetic linkage studies suggest that Alzheimer's disease is not a single homogenous disorder. Nature 347: 194-197
59. Szelies B, Herholz K, Pawlik G, Beil C, Wienhard K, Heiss WD (1986) Zerebraler Glukosestoffwechsel bei praeseniler Demenz vom Alzheimer Typ - Verlaufskontrolle unter Therapie mit muskarinergem Cholinagonisten. Fortschr Neurol Psychiat 11: 364-373
60. Szelies B, Karenberg A (1986) Störungen des Glukosestoffwechsels bei Pickscher Erkrankung. Fortschr Neurol Psychiat 54: 393-397
61. Tomlinson BE, Blessed G, Roth M (1968) Observations on the brains of non-demented old people. J Neurol Sci 7: 331-356
62. Tomlinson BE, Blessed G, Roth M (1970) Observations on the brains of demented old people. J Neurol Sci 11: 205-242
63. Tune L, Brandt J, Frost JJ, Harris G, Mayberg H, Steele C, Burns A, Sapp J, Folstein MF, Wagner HN (1991) Physostigmine in Alzheimer's disease - effects on cognitive-functioning, cerebral glucose-metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon-emission tomography. Acta Psychiatr Scand 93 [Suppl 366]: 61-65
64. Weinstein HC, Haan J, van Royen EO, Derix MMA, Lanser JBK, van der Zant F, Dunnewold RJW, van Kroonenburgh MJPG, Pauwels EKJ, van der Velde EA, Hijdra A, Buruma OJS (1991) SPECT in the diagnosis of Alzheimer's disease and multi-infarct dementia. Clin Neurol Neurosurg 93: 39-43
65. Weltgesundheitsorganisation (1991) Dilling H, Mombour W, Schmidt MH (eds) Internationale Klassifikation psychischer Störungen ICD 10 Kp V (F). Klinischdiagnostische Leitlinien. Huber, Bern